Pinedo HM - Search Results

1

Current status of systemic chemotherapy in the treatment of advanced ovarian cancer with emphasis on CHAP-5.

Neijt JP, ten Bokkel Huinink WW, van der Burg ME, van Oosterom AT, Vriesendorp R, Pinedo HM. Neijt JP, et al. Among authors: pinedo hm. Radiother Oncol. 1984 Jun;2(1):19-29. doi: 10.1016/s0167-8140(84)80034-1. Radiother Oncol. 1984. PMID: 6438704

2

Phase II study of iproplatin in advanced ovarian carcinoma.

Sessa C, Vermorken J, Renard J, Kaye S, Smith D, ten Bokkel Huinink W, Cavalli F, Pinedo H. Sessa C, et al. J Clin Oncol. 1988 Jan;6(1):98-105. doi: 10.1200/JCO.1988.6.1.98. J Clin Oncol. 1988. PMID: 3335895

3

Combination chemotherapy with or without hexamethylmelamine in alkylating-agent resistant ovarian carcinoma.

Neijt JP, ten Bokkel Huinink WW, van der Burg ME, van Oosterom AT, Kooyman CD, van Houwelingen JC, Pinedo HM. Neijt JP, et al. Among authors: pinedo hm. Cancer. 1984 Apr 1;53(7):1467-72. doi: 10.1002/1097-0142(19840401)53:7<1467::aid-cncr2820530707>3.0.co;2-2. Cancer. 1984. PMID: 6421472

4

Treatment of advanced ovarian carcinoma with a combination of hexmethylmelamine, cyclophosphamide, methotrexate, and 5-fluorourcil (hexa-CAF) in patients with and without previous treatment.

Neijt JP, van Lindert AC, Vendrik CP, Roozendaal KJ, Struyvenberg A, Pinedo HM. Neijt JP, et al. Among authors: pinedo hm. Cancer Treat Rep. 1980 Feb-Mar;64(2-3):323-6. Cancer Treat Rep. 1980. PMID: 6773656

5

Hexa-CAF combination chemotherapy and other multiple-drug regimens in advanced ovarian carcinoma: present and future.

Neijt JP, van Lindert AC, Vendrik CP, Roozendaal KJ, Struyvenberg A, Pinedo HM. Neijt JP, et al. Among authors: pinedo hm. Neth J Med. 1979;22(2):38-44. Neth J Med. 1979. PMID: 107464 Clinical Trial. No abstract available.

6

Multicenter phase II study of spiroplatin.

Tanis BC, Vermorken JB, ten Bokkel Huinink WW, van Oosterom AT, Splinter TA, Vendrik KJ, Sleijfer DT, van der Burg ME, van der Putten E, Pinedo HM. Tanis BC, et al. Among authors: pinedo hm. Oncology. 1992;49(2):99-103. doi: 10.1159/000227020. Oncology. 1992. PMID: 1574259 Clinical Trial.

7

Pharmacology of 5'-deoxy-5-fluorouridine in patients with resistant ovarian cancer.

de Bruijn EA, van Oosterom AT, Tjaden UR, Reeuwijk HJ, Pinedo HM. de Bruijn EA, et al. Among authors: pinedo hm. Cancer Res. 1985 Nov;45(11 Pt 2):5931-5. Cancer Res. 1985. PMID: 2932219

8

Mitomycin C-induced hemolytic uremic syndrome. Six case reports and review of the literature on renal, pulmonary and cardiac side effects of the drug.

Verweij J, van der Burg ME, Pinedo HM. Verweij J, et al. Among authors: pinedo hm. Radiother Oncol. 1987 Jan;8(1):33-41. doi: 10.1016/s0167-8140(87)80020-8. Radiother Oncol. 1987. PMID: 3101142 Review.

9

Five-year survival of patients with disseminated nonseminomatous testicular cancer treated with cisplatin, vinblastine, and bleomycin.

Stoter G, Vendrik CP, Struyvenberg A, Sleyfer DT, Vriesendorp R, Schraffordt Koops H, van Oosterom AT, ten Bokkel Huinink WW, Pinedo HM. Stoter G, et al. Among authors: pinedo hm. Cancer. 1984 Oct 15;54(8):1521-4. doi: 10.1002/1097-0142(19841015)54:8<1521::aid-cncr2820540808>3.0.co;2-8. Cancer. 1984. PMID: 6206937

10

Ten-year survival and late sequelae in testicular cancer patients treated with cisplatin, vinblastine, and bleomycin.

Stoter G, Koopman A, Vendrik CP, Struyvenberg A, Sleyfer DT, Willemse PH, Schraffordt Koops H, van Oosterom AT, ten Bokkel Huinink WW, Pinedo HM. Stoter G, et al. Among authors: pinedo hm. J Clin Oncol. 1989 Aug;7(8):1099-104. doi: 10.1200/JCO.1989.7.8.1099. J Clin Oncol. 1989. PMID: 2474060

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

697 results

Search Page

Filters